Type of Adverse Events |
ADA Patients without Uveitis (n=12, 14.5 Patient-Years) |
ADA Patients with Uveitis (n=13, 27.75 Patient-Years) |
ETA Patients (n=49, 75.25 Patient-Years) |
Infectious AEs, rate |
13.8 per 100 patient-years |
51.4 per 100 patient-years |
39.9 per 100 patient-years |
Acute respiratory virus infection |
0 |
11 |
25 |
Acute bronchitis |
0 |
1 |
1 |
Blepharitis |
1 |
0 |
0 |
Streptococcal pyoderma |
1 |
0 |
0 |
Rotavirus-induced diarrhea |
0 |
1 |
0 |
Urinary tract infections |
0 |
1 |
0 |
Herpes zoster |
0 |
0 |
1 |
Sinusitis |
0 |
0 |
1 |
Non-infectious AEs, rate |
34.5 per 100 patient-years |
7.3 per 100 patient-years |
6.6 per 100 patient-years |
Femoral fracture |
3* |
0 |
0 |
Nasal hemorrhage |
1 |
0 |
0 |
Thrombocytopenia |
1 |
0 |
0 |
Injection site pain |
0 |
1 |
0 |
Hemorrhagic rash |
0 |
1 |
0 |
Allergic reaction |
0 |
0 |
1 |
Elevated transaminase level |
0 |
0 |
2 |
Neutropenia |
0 |
0 |
2 |